Douglas A. Treco, CEO at Inozyme Pharma, Inc. (INZY), sold 15,046 shares at $6.94 ($104K) on 2024-04-02, disclosed to the SEC on 2024-04-03.
Open-market sale of $104k INZY by CEO. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Something here stands out, but not much.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $6.94 | 7,523 | $52K | 50.0% |
| 2 | $6.94 | 7,523 | $52K | 50.0% |
| Total | $6.94 avg | 15,046 | $104K | 100% |
| Filing → |